The Pharma Perspective
The Pharma Perspective offers clear, insightful conversations on the ideas, challenges, and innovations shaping the pharmaceutical industry. It covers topics like health economics, market access, clinical evidence, and policy, providing practical insights for consultants, researchers, and industry professionals. Hosted by Mirko von Hein, the podcast aims to cut through complexity and share viewpoints that help listeners stay informed and succeed in pharma.
Episodes
Will AI Replace Medical Writers? | Virginia Chachati | EP 9
Medical writing rates, AI-proof writing tests, and the telltale signs of AI-generated content: on this episode of The Pharma Perspective, pharmacist turned medical writer Virginia Chachati breaks down what it takes to build a writing career in healthcare today. Virginia explains how she went from community pharmacy to creating health videos with the NHS, why copywriting in healthcare comes with st
Most Favored Nation Pricing, Tariffs & the Rise of China | Neil Grubert | EP 8
Most Favored Nation (MFN) drug pricing, pharma tariffs, and China overtaking the US in new drug launches: on this episode of The Pharma Perspective, market access and policy expert Neil Grubert breaks down the forces reshaping how the world prices and pays for medicines. Neil explains what Trump's Executive Order on Most Favored Nation pricing really means, why the US funds an estimated 75% of glo
Pharma's Worst Job Market in 30 Years: Top Recruiter Reveals What to Do Now | Grant Coren | EP 7
In this episode of The Pharma Perspective podcast, Grant Coren, life science recruiter with over 30 years of experience and founder of his own executive search practice, discusses the state of the pharma job market in 2026, why hiring has slowed across pharma, biotech, and CRO alike, how AI screening tools and applicant tracking systems are changing — and distorting — the recruitment process, why
Rethinking Medications: From Academic Detailing to Broken Drug Regulation | Jerry Avorn | EP 6
In this episode of The Pharma Perspective podcast, Jerry Avorn, Professor of Medicine at Harvard Medical School and author of "Rethinking Medications," discusses the state of drug regulation in the United States, the problems with accelerated approvals and missing confirmatory trials, how academic detailing can change prescribing behavior more effectively than guidelines, the misuse of surrogate e
Measuring What Patients Actually Care About | Katja Rüdell | EP 5
In this episode of The Pharma Perspective podcast, Katja Rüdell, one of the world's leading clinical outcome assessment and patient-reported outcomes experts, discusses the role of PROs in drug development, regulatory expectations from FDA and EMA for outcome measure validation, the challenges of developing fit-for-purpose COA instruments, the evolution of patient-centred research in pharmaceutica
What Does the ABPI Actually Do? | Jack Neill-Hall | EP 4
In this episode of The Pharma Perspective podcast, Jack Neill-Hall from the Association of the British Pharmaceutical Industry (ABPI) discusses the UK pharmaceutical pricing environment, NICE's cost-effectiveness threshold and appraisal process for NHS medicines, industry transparency through the Code of Practice and Disclosure UK, healthcare budget allocation, and why some medicines never reach U
Is Raising the NICE Threshold Bad for NHS Patients? | Karl Claxton | EP 3
In this episode of "The Pharma Perspective", I speak with Karl Claxton, Professor of Economics at the University of York and founding NICE Appraisal Committee member, about his open letter to the UK Prime Minister on pharmaceutical pricing for branded medicines, why raising the NICE willingness-to-pay threshold would be catastrophic for NHS patients, and his proposals for fundamentally reforming h
Starting a Pharma Consultancy in a Pandemic: The PharmacoEvidence Story | Barinder Singh | EP 2
Join me in my discussion with Barinder Singh, Founder of PharmacoEvidence, who quit his stable HEOR job in 2020—amid a pandemic and with a baby on the way—to start his own consultancy. In this episode of The Pharma Perspective, we explore how that bold decision turned into a thriving 40+ person company leading NICE submissions with AI-validated methods. We also talk about what it really takes to b
How to Build a Meaningful Pharma Career – Leadership Lessons from a GM | Peter Wickersham | EP 1
Join me in my discussion with Peter Wickersham, Pharma Vice President & General Manager with 25+ years of experience, as we explore leadership, career growth, and navigating the evolving pharma industry in the age of AI. In this episode of Pharma Perspectives, Peter shares his insights on the challenges and opportunities shaping pharma today, offering practical advice for professionals interested
Recommended
LOVE SOMEONE with Delilah
Classical Christian Education
Veritas Vox - The Voice of Classical Christian Education
Enjoy Teaching Again | Elementary, Teacher Burnout, Student Behavior, SEL, Classroom Management
Entrepreneur Kids Legacy Show - Family Motivation, Business Boss Babies, Inspirational Speakers and Healthy fun food
McKinsey on Consumer and Retail
megahired.com
Telli Talks with Telli Swift
Harmonize Your Life: Conversation on Self-Care for Women of Color
Lighting the Legal Career Path
High Performance Mindset | Learn from World-Class Leaders, Consultants, Athletes & Coaches about Mindset
Pintastic® Pinterest Podcast
